ALLMedicine™ Drooling Center

Sep 22nd, 2020 - The best surgical option to treat drooling in neurodisabilitiesis still under debate. The aim of this study is to describe the technique of subtotal functional sialoadenectomy (SFS) (i.e. four-duct ligation (4-DL)together with bilateral sublingual...

Sep 18th, 2020 - Drooling is common in children with neurological disorders, but its management is very challenging, Scopolamine transdermal patch (STP) appears to be useful in controlling drooling, although it is not approved for this indication and there are lim...

Sep 11th, 2020 - The main aim of this study was to determine the impact of botulinum toxin A (BTX-A) on severity and frequency of drooling in children with Cerebral Palsy (CP) secondary to Congenital Zika Syndrome (CZS). This is a prospective longitudinal observat...

Sep 2nd, 2020 - Hypersalivation and drooling are commonly reported in clozapine-treated patients. Current management strategies have been evaluated using subjective measures. Many case reports describe the successful use of atropine in the treatment of the condit...

Aug 28th, 2020 - Clozapine-induced sialorrhea (CIS) is a common side effect of clozapine. There is no established standard treatment for CIS since the underlying mechanism remains unknown. This study aimed to elucidate the mechanisms involved in CIS. In our clinic...

Jul 16th, 2010 - Many individuals with neurological problems or anatomical abnormalities of the jaw, lips or oral cavity may drool, which can impact on health and quality of life. A thorough evaluation of the patient's history, examination of the oral region by a ...

Sep 22nd, 2020 - The best surgical option to treat drooling in neurodisabilitiesis still under debate. The aim of this study is to describe the technique of subtotal functional sialoadenectomy (SFS) (i.e. four-duct ligation (4-DL)together with bilateral sublingual...

Sep 18th, 2020 - Drooling is common in children with neurological disorders, but its management is very challenging, Scopolamine transdermal patch (STP) appears to be useful in controlling drooling, although it is not approved for this indication and there are lim...

Sep 11th, 2020 - The main aim of this study was to determine the impact of botulinum toxin A (BTX-A) on severity and frequency of drooling in children with Cerebral Palsy (CP) secondary to Congenital Zika Syndrome (CZS). This is a prospective longitudinal observat...

Sep 2nd, 2020 - Hypersalivation and drooling are commonly reported in clozapine-treated patients. Current management strategies have been evaluated using subjective measures. Many case reports describe the successful use of atropine in the treatment of the condit...

Aug 28th, 2020 - Clozapine-induced sialorrhea (CIS) is a common side effect of clozapine. There is no established standard treatment for CIS since the underlying mechanism remains unknown. This study aimed to elucidate the mechanisms involved in CIS. In our clinic...

Sep 3rd, 2019 - An 83-year-old woman with hypertension, hypothyroidism, and a history of depression presented to the emergency department with acute shortness of breath and hypoxia. She was found to have submassive pulmonary embolism, and a heparin infusion was s.

Jul 5th, 2018 - Multi-flap reconstruction after surgery for head and neck cancer led to "modest" functional and aesthetic improvement and high complication rates and costs, a meta-analysis of 24 published studies showed. Substantial proportions of patients remain...

Jun 1st, 2018 - A 59-year-old woman presented with drooling out of the left side of her mouth and inability to close her left eye. She had no ear pain, hearing loss, or skin rash.

Jan 2nd, 2018 - NEW YORK (Reuters Health) - In children with neurodisability, glycopyrronium liquid may be a better choice to address drooling than a hyoscine skin patch, according to new research from the UK. "We concluded that glycopyrronium should be considere...

Sep 28th, 2017 - VANCOUVER—IncobotulinumtoxinA may help treat sialorrhea in patients with Parkinson’s disease or other neurologic conditions, according to a study presented at the 21st International Congress of Parkinson’s Disease and Movement Disorders. “Results.